The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to ...

Swiss drugmaker Roche said on Monday it would advance testing of an antibiotic against a common drug-resistant bacteria that ...

Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments ...

A group of advisers to the Food and Drug Administration said Roche Holding AG needs to study its blood cancer treatment in more American patients before its use can be expanded. Independent ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Schindler Ps, Novartis, Sandoz Group, Swiss Re, Zurich Insurance, Roche Holding and Sonova gained 0.9 to 1.2%. ABB, Lindt & Spruengli, UBS Group and Geberit also ended on firm note. VAT Group ...

1 As the leader in companion diagnostics, Roche's broad CDx portfolio helps enable informed clinical decisions and improved patient outcomes. Basel, 14 May 2025 - Roche (SIX: RO, ROG; OTCQX ...

(Bloomberg) — Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive order to cut prescription drug costs. Last month ...

Roche Holding AG said it would need to reconsider planned US investments if President Donald Trump implements an executive order to cut prescription drug costs. Last month, Roche said it planned to ...